Drug giant in jobs warning

Drug maker GlaxoSmithKline today warned of job losses as it announced cost-cutting plans to offset falling sales of diabetes treatment Avandia.

The group, which was rocked earlier this year by health scares surrounding Avandia, confirmed it would need to axe jobs as part of a drive to save up to £700m (€1bn) in annual costs within three years.